Article: ADAC Announces Record Third Quarter Results; 25 Percent Increase in Q3 Earnings Per Share, Excluding One-Time Charge.

MILPITAS, Calif.--(BW HealthWire)--July 23, 1997--ADAC Laboratories (NASDAQ:ADAC), the world market share leader in nuclear medicine, today announced record results for its third fiscal quarter of 1997 ended June 29, 1997. The Company reported a 25 percent increase in earnings per share and its eleventh consecutive quarterly revenue and operating income increase, excluding the effect of the previously announced $5.9 million one-time charge for in-process research and development related to the purchase of Cortet, Inc. and certain uncompleted acquisition costs and related expenses.

ADAC generated record revenues of $71.5 million in the third quarter, a 15 ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!